Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer Journal Article


Authors: Gordhandas, S. B.; Manning-Geist, B.; Henson, C.; Iyer, G.; Gardner, G. J.; Sonoda, Y.; Moore, K. N.; Aghajanian, C.; Chui, M. H.; Grisham, R. N.
Article Title: Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
Abstract: DNA-dependent protein kinase (DNA-PK) plays a crucial role in repair of DNA double-strand breaks by facilitating non-homologous end-joining. Inhibitors of DNA-PK have the potential to block DNA repair and enhance DNA-damaging agents. Peposertib (M3814) is a DNA-PK inhibitor that has shown preclinical activity in combination with DNA-damaging agents, including ionizing radiation (IR) and topoisomerase II inhibitors. Here we evaluated the activity of peposertib (M3814) in combination with radiation in a mouse xenograft model of HPV-associated cervical cancer. Athymic nude female mice with established tumors derived from HeLa cells injected into the flank were treated with vehicle alone (n = 3), IR alone (n = 4), and peposertib (M38814) in combination with IR (M3814 + IR; n = 4). While IR alone was associated with a trend towards decreased tumor volume compared with untreated, only the M3814 + IR treatment arm was associated with consistent and significant reduction in tumor burden, which correlated with higher levels of γ-H2AX in tumor cells, a marker of double-strand DNA breaks. Our data support further clinical evaluation of the combination of peposertib (M38814) and IR in cervical cancer. © 2022, The Author(s).
Journal Title: Scientific Reports
Volume: 12
ISSN: 2045-2322
Publisher: Nature Publishing Group  
Date Published: 2022-01-19
Start Page: 974
Language: English
DOI: 10.1038/s41598-021-04618-5
PROVIDER: scopus
PMCID: PMC8770623
PUBMED: 35046420
DOI/URL:
Notes: Article -- Export Date: 1 February 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ginger J Gardner
    270 Gardner
  2. Yukio Sonoda
    472 Sonoda
  3. Gopakumar Vasudeva Iyer
    342 Iyer
  4. Rachel Nicole Grisham
    169 Grisham
  5. Michael Herman Chui
    60 Chui